AI assistant
Sending…
Lucid Diagnostics Inc. — Director's Dealing 2022
Feb 24, 2022
33983_dirs_2022-02-24_b0282bb8-f6f6-412a-99e0-4b76be8e241f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Lucid Diagnostics Inc. (LUCD)
CIK: 0001799011
Period of Report: 2022-02-18
Reporting Person: SOKOLOV JACQUE J (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-02-18 | Employee stock option (right to buy) | $3.95 | A | 59000 | Acquired | 2032-02-18 | Common stock (59000) | Direct |
Footnotes
F1: The option vests in 12 quarterly installments, with first installment vesting March 31, 2022.
More from Lucid Diagnostics Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 24
Earnings Release
2026
May 14
Interim / Quarterly Report
2026
May 13
Annual Report
2026
Apr 30
Capital/Financing Update
2026
Apr 23
Regulatory Filings
2026
Mar 27
Capital/Financing Update
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25